From: Analysis of selected polymorphisms in FOXP3 gene in a cohort of Egyptian patients with schizophrenia
Gender | Foxp3 polymorphism | Case (N = 125) N (%) | Control (N = 160) N (%) | OR (95% CI) | P-value |
---|---|---|---|---|---|
Female | rs3761548 (C/A) | ||||
AA | 3 (4.2) | 5 (5.4) | 0.77 (0.18–3.36) | 0.73* | |
AC | 22 (31.0) | 33 (35.5) | 0.82 (0.42–1.58) | 0.55 | |
CC | 46 (64.8) | 55 (59.1) | 1.27 (0.67–2.41) | 0.46 | |
A | 28 (19.7) | 43 (23.1) | 0.82 (0.48–1.39) | 0.46 | |
C | 114 (80.3) | 143 (76.9) | 1.22 (0.72–2.09) | 0.46 | |
 | HWE | 0.80 | 0.77 |  |  |
Male | A | 8 (14.8) | 6 (9.0) | 1.77 (0.57–5.45) | 0.32 |
C | 46 (85.2) | 61 (91.0) | 0.57 (0.18–1.74) | 0.32 | |
Female | rs3761549 (C/T) | ||||
TT | 2 (2.8) | 2 (2.2) | 1.31 (0.18–9.59) | 0.78* | |
CT | 29 (40.8) | 38 (40.9) | 0.99 (0.53–1.87) | 1.00 | |
CC | 40 (56.3) | 53 (57.0) | 0.97 (0.52–1.82) | 0.93 | |
T | 33 (23.2) | 42 (22.6) | 1.04 (0.62–1.75) | 0.89 | |
C | 109 (76.8) | 144 (77.4) | 0.96 (0.57–1.62) | 0.89 | |
 | HWE | 0.77 | 0.77 |  |  |
Male | T | 18 (33.3) | 12 (17.9) | 2.29 (0.98–5.32) | 0.054 |
C | 36 (66.7) | 55 (82.1) | 0.44 (0.19–1.01) | 0.054 | |
Female | rs2232365 (A/G) | ||||
AA | 7 (9.9) | 10 (10.8) | 1.02 (0.37–2.81) | 0.97 | |
AG | 31 (43.7) | 46 (49.5) | 0.79 (0.42–1.47) | 0.46 | |
GG | 33 (46.5) | 37 (39.8) | 1.10 (0.58–2.08) | 0.76 | |
A | 45 (31.6) | 66 (35.5) | 0.84 (0.53–1.34) | 0.47 | |
G | 97 (68.3) | 120 (64.5) | 1.18 (0.75–1.89) | 0.47 | |
 | HWE | 0.68 | 0.65 |  |  |
Male | A | 24 (44.4) | 32 (47.8) | 0.88 (0.43–1.79) | 0.72 |
G | 30 (55.6) | 35 (52.2) | 1.14 (0.57–2.35) | 0.72 |